The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study to evaluate the safety and efficacy of MEDI4736 in combination with tremelimumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN).
 
Lillian L. Siu
Leadership - Agios (I)
Stock and Other Ownership Interests - Agios (I); Entremed (I)
Consulting or Advisory Role - Boehringer Ingelheim; Daiichi Sankyo; Merck; Novartis (Inst); Oncoethix
Research Funding - Abraxis BioScience; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Celgene; Genentech/Roche; GlaxoSmithKline; Karyopharm Therapeutics; MedImmune; Merck; Novartis; Pfizer; Regeneron
 
Kyriakos P. Papadopoulos
Research Funding - Abbvie (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Novartis (Inst); Onyx (Inst); Sanofi (Inst)
 
Frank Yung-Chin Tsai
Research Funding - MedImmune (Inst)
 
Aaron Richard Hansen
Research Funding - MedImmune (Inst)
 
Paul B. Robbins
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
 
Xia Li
Employment - MedImmune
 
Dominic W Lai
Employment - MedImmune
 
John A. Blake-Haskins
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline (I)
 
Matthew G. Fury
Employment - Regeneron (I)
Stock and Other Ownership Interests - Regeneron (I)
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Egenix; Novartis
Research Funding - AstraZeneca/MedImmune; Novartis; Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron (I)